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Abstract Stromal cell-derived factor 1a (SDF-1) is not
only a major chemotactic factor, but also an inducer of
angiogenesis. The effects of SDF-1a on the left ventricular
remodeling in a rat myocardial infarction (MI) model were
analyzed. Myocardial infarction was induced by ligation of
the left coronary artery in rats. 0.5 9 10
10 pfu/ml AdV-
SDF-1 or 0.5 9 10
10 pfu/ml Adv-LacZ were immediately
injected into the infarcted myocardium, 120 ll cell-free
PBS were injected into the infarcted region or the myo-
cardial wall in control, and sham group, respectively. We
found that AdV-SDF-1 group had higher LVSP and ±dP/
dtmax, lower LVEDP compared to control or Adv-LacZ
group. The number of c-Kit
? stem cells, and gene
expression of SDF-1, VEGF and bFGF were obviously
increased, which was associated with reduced infarct size,
thicker left ventricle wall, greater vascular density and
cardiocytes density in infarcted hearts of AdV-SDF-1
group. Furthermore, the expression of collagen type I and
type III mRNA, and collagen accumulation in the infarcted
area was lower, which was associated with decreased TGF-
b1, TIMP-1 and TIMP-2 expression in AdV-SDF-1 group.
Conclusion: SDF-1a could improve cardiac structure and
function after Myocardial infarction through angiogenic
and anti-ﬁbrotic actions.
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Introduction
The transplantation of multiple stem cell types at the time
of myocardial infarction has been shown to improve left
ventricular perfusion and/or function in preclinical and
clinical studies. Cardiac stem cell (CSC) is pluripotent,
adult stem cells and mostly resides within the bone marrow
or heart. In contrast to other stem cells, c-Kit
? or Sca
?
Cardiac stem cells can differentiate not only into cardio-
myocytes, but also into vascular endothelial cells [1]. In
vivo, cardiac stem cells directly injected into an infarcted
heart have been shown to induce myocardial regeneration
and improve cardiac function. More importantly, when
given intravenously after infarction, these cells targeted
injured myocardium and differentiated into cardiomyo-
cytes [2, 3]. These observations prompted a search for
chemotactic factors that facilitate this ‘‘homing’’ process. If
the effects of translocated stem cells prove important in
improving cardiac function, the ability to harness or aug-
ment these effects may be possible through gene transfer
strategies.
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DOI 10.1007/s11033-009-9642-zIt is interesting that the cytokine stromal cell-derived
factor 1a (SDF-1a or CXCL12) is a major chemotactic
factors. CXCR4 is the cell surface receptor for SDF-1,
and is expressed on early hematopoietic stem cells
(HSC), cardiac stem or precursor cells and endothelial
progenitor cells (EPC) [1] .M aa n do u rs t u d yr e c e n t l y
demonstrated that SDF-1 is expressed increasedly by the
heart immediately after an acute myocardial infarction
[4]. And the SDF-1 expression at a time of myocardial
infarction (MI) can restore stem cell homing to damaged
cardiac tissue [2, 5]. However, the effect of intrinsic
SDF-1 upregulated expression is, transient and insufﬁ-
cient for cardiac repair [6].Therefore, forced expression
of SDF-1a by adenoviral gene delivery and SDF-1a
protein increased the recruitment of stem cells to the
i n f a r c t e dh e a r t .I na d d i t i o n ,S D F - 1i sa l s oa ni n d u c e ro f
angiogenesis. SDF-1 promotes not only EPCs (CD133 is
one of its characteristic markers) recruitment into the
ischemic muscles to promote angiogenesis, but also
induces bone marrow derived-c-Kit
? stem cells to dif-
ferentiate into EPCs and endothelial cells [7–10]. These
ﬁndings raise the possibility that SDF-1 has the effects
on myocardial structure and function via myogenesis and
angiogenesis. However, little information is available
about the role of SDF-1 on left ventricular remodeling
after MI.
A model of MI in the rat has been created by Left
anterior descending artery (LAD) ligation, which results in
severe heart failure characterized by increased cardiac
ﬁbrosis and left ventricular (LV) dilation. The purpose of
this study was to investigate the following topics: (1)
whether SDF-1 results in homing of c-Kit
? cardiac stem
cells to the injured myocardium and (2) whether the
myoangiogenesis effects of SDF-1 mediated stem cells on
left ventricular remodeling.
Methods
Myocardial infarction model and viral transduction
Myocardial infarction (MI) was performed by the ligation
of LAD as described previously [7]. Brieﬂy, male Wistar
inbred rats (280–320 g) were anesthetized with ketamine
(50 mg/kg IP) and xylazine (10 mg/kg IP) and tracheally
ventilated with room air using a columbus ventilator
(HX-300, Taimeng Instruments, and Chendu, China). After
left lateral thoracotomy in the fourth intercostal space,
LAD was ligated. Before chest closure, infarction was
conﬁrmed by observation of a demarcation of injury with
blanching of the myocardium and electrocardiograph.
Experimental animals were randomized for each group.
After MI induction, 0.5 9 10
10 pfu/ml of AdV.SDF-1 were
separately injected into six different sites (30 ll per site)
for each MI heart in the AdV.SDF-1 group with a 30-gauge
tuberculin syringe. Two injection sites were in the myo-
cardium peri-infarction area and two within the infarction
area and Control or AdV.LacZ group received the same MI
operation and was injected with an equivalent volume of
the cell-free PBS or AdV.LacZ, respectively. The sham
group underwent the identical surgery with neither ligation
of the coronary artery nor adenovirus injection. Penicillin
(150,000 U/ml) was given intravenously before each
operation and buprenorphine hydrochloride (0.05 mg/kg)
was administered subcutaneously twice a day for the ﬁrst
48 h after operation.
Peripheral blood analysis
0.5 ml blood sample was serially (on days 3, 7, 14 and 28)
drawn from the tail vein to measure peripheral mononu-
clear cell count. Total peripheral blood mononuclear cells
(PBMNCs) count was determined using a Neubauer
hematocytometer (Fisher Scientiﬁc) [11].
Western blotting and ELISA
Three, 7, 14, and 28 days after treatment (each time
point, n = 5), rats were killed and peripheral blood
(10 ml) was collected to measure plasma levels of stro-
mal cell-derived factor 1a (SDF-1a)b ye n z y m e -
linked immunosorbent assay (ELISA).Myocardium tissue
extracts of the infarction area and peri-infarction area
were clariﬁed and protein content quantiﬁed by Bradford
method. Subsequently, the levels of SDF-1a in the
infarction area and peri-infarction area of Myocardium
were measured by use of the SDF-1a (R&D Systems).
And left ventricle tissue extracts were clariﬁed and pro-
tein content quantiﬁed by Bradford method. Thirty
micrograms of the clariﬁed extracts was run in 12% SDS–
PAGE followed by transfer to a nitrocellulose membrane.
Western analysis was carried out using the following
primary antibodies: transforming growth factor-b1( T G F -
b1), tissue inhibitor of metalloproteinase-1 (TIMP-1),
TIMP-2 (1:500, Santa Cruz). After extensive washing,
immunocomplexes were detected with horseradish per-
oxidase-conjugated appropriate secondary antibodies
followed by enhanced chemiluminescence reaction (KPL,
American) [7, 8].
RNA preparation and RT-PCR
Three, 7, 14, and 28 days after treatment (each time
point, n = 5), rats were killed, coronary blood was
washed out with saline, the peri-infarction area (100 mg)
and infarction area (100 mg) of the heart was removed
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123and minced, and total RNA was extracted by the guan-
idinium thiocyanate-phenol chloroform method. Reverse
transcription-polymerase chain reaction (RT-PCR) was
performed to determine expression of the myocardial
cytokines VEGF, basic-FGF, TGF-b1, SDF-1a and its
receptor CXCR4, stem cell factor receptor c-Kit, and
collagen type I and III. The RT-PCR procedure was
performed according to the manufacturer’s recommen-
dation (RT-PCR Kit, Fermentas Life Science, Ontario,
Canada). The primers used in this study are listed in
supplement 1. Quantitative RT-PCR was performed using
SYBR Green Reaction Mix (Eurogentec) on an ABI
PRISM 7900HT Detection System (Applied Biosystems).
Each sample was run in duplicate. The expression of each
gene within the different tissue samples was quantiﬁed
relative to GAPDH expression [11].
Measurement of hemodynamics
Twenty-eight days after treatment, hemodynamic mea-
surements in vivo were performed with the methods as
following. Rats were anesthetized with pentobarbital
sodium (60 mg/kg, i.p.). A carotid artery and femoral
artery were isolated. The two catheters ﬁlled with hepa-
rinized (10 U/ml) saline solution were connected to Sta-
tham pressure transducer (Gould, Saddle Brook, NJ,
USA). The carotid arterial catheter was advanced into the
left ventricle to record ventricular pressure for a brief
period of time. And the femoral artery catheter was
inserted into an isolated femoral artery to monitor mean
arterial pressure (BP), and heart rate (HR). These hemo-
dynamic parameters were monitored simultaneously and
recorded on a thermal pen-writing recorder (RJG- 4122,
Nihon Kohden, Japan) and on an FM magnetic tape
recorder (RM-7000, Sony, Tokyo, Japan). Tapes were
later played back. After the measurements, the heart was
rapidly removed from the killed rats (each group,
n = 10–12) [12].
Histology and morphometric measurement
At day 28 after MI, rat wet weight measured, and then
LV function was assessed. The hearts were quickly
removed and was cut into six transverse slices from apex
to base and processed for histology. Heart infarct size
was measured using triphenyltetrazolium chloride
(TTC).28 days after MI (each group, n = 6). Brieﬂy, left
ventricles were sliced transversely into ﬁve to six sec-
tions approximately 2 mm in thickness and incubated for
30 min in a 1% solution of buffered TTC at 37C. Slices
were photographed with a digital camera with magniﬁ-
cation in order to identify the infarcted myocardium
(unstained by TTC) and the non-ischemic zones (stained
brick-red).All measurements were done by two experi-
enced technicians who were blinded to the treatment
group. The LV-wall thickness was measured at three
widely spaced locations within the scar segment as well
as the non-infarcted region for each slide and the average
of these multiple measurements were calculated. To
estimate an overall degree of ventricular remodeling,
expansion index was computed by our previous method.
The analyses of LV-wall thickness and expansion index
were performed upon two middle slides and the averages
were calculated for each heart (each group, n = 6)
[12–14].
Immunohistochemistry analysis
Seven and 28 days after treatment (each time point,
n = 5), rats were killed. After quick removal of the hearts,
the hearts were immersion ﬁxed in 4% paraformaldehyde
and embedded in optimum cutting temperature (OCT)
compound (Fisher Scientiﬁc, Fair Lawn). Serial transverse
sections of 5 lm were cut across the entire long axis of the
heart and subsequently mounted on slides.
Double-staining immunoﬂuorescence was performed
with speciﬁc primary antibodies. Brieﬂy, frozen tissue
sections were incubated simultaneously with rabbit anti-
human SDF-1a (hSDF-1a,1 : 2 0 0 ,R & DS y s t e m s )a n d
mouse anti-rat Troponin T (Cardiac isoform, cTnt,
2 lg/ml, Neomarkers), mouse anti-rat c-Kit (1:250, Santa
Cruz) and rabbit anti-rat CXCR4 (1:250, Santa Cruz) for
60 min at room temperature, respectively. After a wash-
ing with PBS solution, sections were incubated with a
goat anti-mouse conjugated TRITC IgG (1:250, R&D
Systems) for c-Kit and cTnt, and goat anti-rabbit conju-
g a t e dF I T CI g Gf o rC X C R 4a n dh S D F - 1 a (1:100, Santa
Cruz). Cellular nucleus was stained with 40,6 - d i a m i d i n o -
2-phenylindole (DAPI, 50 lg/ml). The numbers of c-Kit
and CXCR4 positive cells were analyzed ﬁve randomly
selected ﬁelds of the muscle tissue section per high
power ﬁeld (2009) by count method using image pro5.02
[12].
Immunohistology was performed with speciﬁc primary
antibodies against factor vWF-VIII (1:250, Santa Cruz) and
cTnt, respectively. The positive stains were shown as red
ﬂuorescence color with TRITC IgG. Capillary density was
evaluated by counting the number of capillaries in ﬁve
randomly selected ﬁelds of the muscle tissue section
(n = 5, each). The value of cTnt positive red ﬂuorescence
photodensity was analyzed in ﬁve randomly selected ﬁelds
of the muscle tissue section per high power ﬁeld (2009)b y
count densitometric method using image pro5.02 (n = 5,
each).
Mol Biol Rep (2010) 37:1957–1969 1959
123Collagen volume fraction (CVF)
To analyze collagen accumulation, Masson’s trichrome
staining was performed to delineate collagen content as
percent of infarction and peri-infarction area. Sixteen
separate areas of high power ﬁelds (2009) in each section
were visualized under light microscope and photographed
with the same exposure time. The collagen volume fraction
(CVF) in the infarction and peri-infarction area was cal-
culated as the percentage of stained tissue in the sum of
muscle area and connective tissue by densitometric method
using image pro5.02 (each group, n = 6) [15].
Data analysis
The data are expressed as mean ± SD. Statistical signiﬁ-
cance between two groups was determined by paired or
unpaired Student’s t-test. Results for more than two
experimental groups were evaluated by one-way ANOVA
to specify differences between groups. P value 0.05 was
considered signiﬁcantly different.
Results
SDF-1a expression assay and peripheral blood
mononuclear cells (PBMNCs) count
Representative immunoﬂuorescence-stained sections of
the hSDF-1a expression showed in the infarction area
(Fig. 1a, b) of the AdV-SDF-1 group 7 days after MI. SDF-
1 mRNA expression by RT-PCR after MI was increased in
the infarcted cardiac tissues, and the level of SDF-1 mRNA
expression was highest in 3 days after MI (Fig. 1c).
Importantly, the level of SDF-1 protein expression by
ELISA after direct myocardial injection of AdV.SDF-1
was signiﬁcantly increased in the infarcted myocardium
(Fig. 1d). At the same time, there was increase of the SDF-
1 levels in the serum (Fig. 1e). Concomitantly, the number
of PBMNCs was increased on day 3, and then decreased
after MI. Furthermore, the number of PBMNCs in AdV-
SDF-1 group showed a greater increase than the other
group on day 3, and was elevated until day 7, then
decreased thereafter (Fig. 1f). Thus, there was a prolonged
Fig. 1 SDF-1 expression and peripheral blood mononuclear cells
(PBMNCs) count. a, b Immunoﬂuorescence staining for hSDF-1a
expression in the infarction area and non-infarction area 7 day after
MI.RT-PCR for SDF-1 mRNA expression in different time point after
MI (c). ELISA for SDF-1 levels in heart tissues (d) and serum (e)i n
the AdV.SDF-1-group. f PBMNCs counts after MI. Values are
mean ± SD. (n = 5, each). * Denotes P = 0.005 vs. control group.
a 1009; b 4009
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123augmented response of PBMNCs count to SDF-1 after MI
induction.
Effect of SDF-1 on stem and progenitor cell
homing into myocardium
CXCR4 and c-Kit (CD117) mRNA expression levels
increased obviously in the infarcted area of AdV.SDF-1
group compared with control group or AdV.LacZ group.
And CXCR4 mRNA expression was greater than c-Kit
mRNA expression in the infarcted area of AdV.SDF-1
group (Fig. 2a, b). Simultaneously, the heart tissue sections
were immunostained for the presence of c-Kit (CD117) and
CXCR4 positive cells in different groups 7 and 28 days
after treatment. The numbers of c-Kit
? and CXCR4
? cells
were signiﬁcantly higher in the infarct areas with overex-
pression of SDF-1a in the heart of AdV-SDF-1 injection, as
compared with the other group (Fig. 2c–e). Furthermore,
c-Kit
? cells were simultaneously CXCR4
? (Fig. 2f).
Effect of SDF-1 on surviving cardiocytes
and angiogenesis in the heart
The data in Fig. 3 demonstrate that SDF-1, to a greater
extent, increase the area and number of cardiac myocytes
within the infarct zone (Fig. 3a–d).Semi- quantitation
analysis of myocardium in the infracted area showed cTnt
density were higher in AdV.SDF-1-group (P\0.001) as
compared with the control group and AdV.Lac-Z group
(Fig. 3j). The angiogenic effect of SDF-1 overexpression
was measured in terms of blood vessel density in the infarct
regions after immunostaining for vWF-VIII (Fig. 3e–h).
The numbers of blood vessel per area were higher in infarct
regions of the AdV.SDF-1-group (P\0.001) as compared
with the control group and AdV.Lac-Z group (Fig. 3i).
Fig. 2 Representative immunoﬂuorescent staining of homing stem
cells in the myocardium infarction area. a, b c-Kit staining 7 days
after MI. c-Kit positive cells were observed in the infarction area of
the AdV.SDF-1 (a 4009) and control groups (b 4009). c c-Kit and
CXCR4 double-staining 7 days after MI (c 4009). c-Kit
? (arrow
indicated), red ﬂuorescence; cellular nucleus marked by DAPI, blue
ﬂuorescence; CXCR4
? (diamond arrow indicated), green ﬂuores-
cence. c-Kit
? CXCR4
? cells, round arrow indicated. d The number
of c-Kit
? and CXCR4
? cells were analyzed per high power ﬁeld
(2009) by count method using image pro5.02, respectively. Data are
mean ± SD (n = 5 each). e, f RT-PCR analysis of c-Kit (e) and
CXCR4 (f) mRNA expressions in the infarction area. Rat GAPDH
served as an internal control. Data are the means of experiments
carried out in duplicate. Values are mean ± SD. (n = 5, each). *
Denotes P = 0.003 vs. control or AdV.LacZ group
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group.
Measurement of hemodynamics
To conﬁrm whether the over-expression SDF-1 in injured
myocardium would even further improve cardiac func-
tion, we carried out measurement of hemodynamics
28 days after transplantation. Measurement of hemody-
namics in vivo showed that LV function was signiﬁcantly
lower in AdV.SDF-1 group, AdV.LaZ group and control
group than sham group. However, improvement of LV
function was signiﬁcantly greater in AdV.SDF-1 group
than the control group or the AdV.LaZ group. The dif-
ferences of LVSP (P\0.05), ±dp/dtmax and LVEDP
(P\0.05) were statistically signiﬁcant between the three
groups (Table 1).
Quantitative RT-PCR analysis
mRNA expression of TGFb1 in the infarcted area of
AdV.SDF-1 group, control group and AdV.LacZ group
increased obviously compared to that of sham-operated
rats, and was peaked on day 3 or 7 up to approximately 2–3
fold compared to that of sham-operated rats, and then
slowly declined. However, TGFb1 mRNA expression in
the infarcted area of AdV.SDF-1 group also showed no
difference or lower levels compared with control group or
AdV.LacZ group 7–28 days after treatment (Fig. 4a).
Collagen type I and type III mRNA expression levels in the
infarcted area of AdV.SDF-1 group, control group and
AdV.LacZ group increased obviously compared to that of
sham-operated rats. But, Collagen type I and type III
mRNA expression levels in the infarcted area of AdV.SDF-
1 group were lower than the control group or AdV.LacZ
group (Fig. 4c, d). Over-expression SDF-1 in AdV.SDF-1
Fig. 3 Immunoﬂuorescent staining of myocardium and blood vessel.
a–d cTnt staining 28 days after MI. cTnt positive cells were observed
in the infarction area of the control (a), AdV.LacZ (b), AdV.SDF-1
(c) and sham groups (d). e–h Von Willebrand factor (vWF) staining
after MI. blood vessel was observed in the infarction area of the
control (e), AdV.LacZ (f), AdV.SDF-1 (g) and sham groups (h),
respectively. i The number of blood vessel was analyzed per high
power ﬁeld (2009) by count method using image pro5.02, respec-
tively. Data are mean ± SEM (n = 5 each). j The value of cTnt
positive red ﬂuorescence photodensity was analyzed by per high
power ﬁeld (2009) by densitometric method using image pro5.02.
Data are mean ± SEM (n = 5 each). * Denotes P = 0.001 vs.
control or AdV.LacZ group
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123group increased the expression of VEGF and bFGF
mRNA analyzed in the myocardium infarction area (Fig. 4)
after MI, and VEGF and bFGF expression increased
obviously in 3 day after MI and continued until 7–28 days
after MI.
Western blot analysis
Levels of TIMP-1, TIMP-2 and TGF-b1 proteins in the
infarcted area at different time point were analyzed by
Western blotting. There was an increase in TIMP-1, TIMP-
Table 1 Physiologic and hemodynamic parameters on days 28
Sham group (n = 11) Control group (n = 10) Adv-SDF-1 group (n = 12) Adv-LacZ group (n = 10)
HVW/BW (mg/g) 2.146 ± 0.30 1.88 ± 0.22 2.02 ± 0.43 1.85 ± 0.32
HR (BMP) 402 ± 11 375 ± 16 394 ± 15 379 ± 17
LVSP (mmHg) 120 ± 3.1 91 ± 3.71 106 ± 4.3* 92 ± 4.1
LVEDP (mmHg) 3.25 ± 0.53 14.86 ± 0.97 10.01 ± 0.71*
# 13.97 ± 0.98
?dP/dtmax (mmHg/s) 7,781 ± 252 2,870 ± 129 4,330 ± 267*
# 2,967 ± 131
-dP/dtmax (mmHg/s) 6,634 ± 231 1,927 ± 177 3,624 ± 295*
# 2,023 ± 105
?dP/dtmax and -dP/dtmax rate in rise and fall of ventricular pressure, respectively. Data are mean ± SEM (n = 7–10)
HVW heart ventricular weight, BW body weight, LVSP left ventricular systolic pressure, LVEDP left ventricular end-diastolic pressure
* Denotes P\0.005 vs. control group
# Denotes P\0.005 vs. sham group
Fig. 4 SYBR Green real-time PCR analysis of TGF-b1 in infarcted
(a) and noninfarcted (b) myocardium, and of collagen type I (c), type
III (d), bFGF (e) and VEGF (f) mRNA expression in infarcted
myocardium. Data were processed with a specially designed software
program based on Ct values of each sample and normalized to
GAPDH. Bars represent mRNA levels relative to GAPDH mRNA
level for control, AdV.LacZ, AdV.SDF-1 and sham group. Data are
the means of experiments carried out in duplicate. Values are
mean ± SD. (n = 5 each). * P = 0.002 vs. control or AdV.LacZ
group. VEGF vascular endothelial growth factor, basic-FGF basic
ﬁbroblast growth factor
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1232 and TGF-b1 protein in the infarcted area in both the
AdV.SDF-1 group and control group compared to sham
group at each time point. Highest TIMP-1, TIMP-2 and
TGF-b1 expression was noted on day 14, 7 or 7 in different
group, respectively. However, there was a decrease in
TGF-b1, TIMP-1 and TIMP-2 protein in the infarcted area
in the AdV.SDF-1 group compared to the control group at
each time point (Fig. 5). And above these changes were no
difference between the control group and AdV.LacZ group
(data not shown).
Effect of SDF-1 on heart histology and morphology
Representative picture of myocardial infarction 28 days
after surgery (Fig. 6a–d). As shown in Fig. 7g, k, new or
survivaling myocardium was located either in the middle of
the scar or adjacent to the border zone. This type of pattern
was not observed in any of the hearts that received medium
injection only or AdV-LacZ. In contrast, the infarcted area
in control group and AdV-LacZ group showed transmu-
ral and thin scar tissue composed of collagen (Fig. 5e, f).
Representative Masson’s trichrome-stained sections
showed more collagen accumulation in the infarcted area
and peri-infarction area 28 day after MI in control group or
AdV-LacZ group (Fig. 5i, j) than AdV-SDF-1 group
(Fig. 5k), semi-quantitative analysis indicated that collagen
volume fraction in the infarcted area was signiﬁcantly
decreased in AdV-SDF-1 group compared to control
group or AdV-LacZ group (Fig. 7a). Marked increases in
the average LV wall thickness were also observed in the
AdV-SDF-1 hearts (Fig. 7b). Moreover, infarct size was
signiﬁcantly reduced in AdV-SDF-1 group as compared
with the control group (Fig. 7c). Quantitative analysis of
cavitary dilatation and wall thickness in all hearts of three
groups revealed thatAdV-SDF-1injection animals displayed
signiﬁcantly less ventricular dilation than control group or
AdV-LacZ group. The expansion index was signiﬁcantly
lower in AdV-SDF-1 group than in control group (Fig. 7d).
Discussion
Presently, isolation of cardiac stem cells was based
exclusively on the expression of a stem cell-related surface
antigen: c-kit and Sca-1. Freshly isolated c-kit
? Lin
- cells
from heart were found to be self-renewing, clonogenic, and
multi-potent, exhibiting biochemical differentiation into
the myogenic cell, smooth muscle cell, or endothelial cell
lineage [1–3, 16]. Interestingly, Sca-1
? c-Kit
- cells from
mice hearts were induced in vitro to differentiate toward
the cardiac myogenic lineage in response to 50-azacytidine
[17]. Obviously, cardiac stem cells appear to be a mixture
of different subpopulations. In this study, we selected the
marker: c-Kit as identiﬁcation index of cardiac stem cell,
and c-Kit
? cells in the damaged heart were observed. We
found c-Kit
? cells increased signiﬁcantly in the Adv-SDF-
1 group than the other group, which were directly mediated
by SDF-1/CXCR4.
It is interesting that Ratajczak et al. have reported that
cells expressing early cardiac markers reside in the bone
Fig. 5 Western blotting
analysis of TGF-b1, TIMP-1
and TIMP-2 in infarcted
myocardium. Bars represent
protein levels relative to b-tubin
for control group, sham group
and AdV-SDF-1 group. Data are
the means of experiments
carried out in duplicate. Values
are mean ± SD. * Denotes
P = 0.004 vs. sham or control
group (n = 5 each)
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123marrow and are mobilized into the peripheral blood after
myocardial infarction. Furthermore, Cimini’ study indi-
cated that interventions that increase the inﬁltration of bone
marrow derived c-kit
? cells to the infarcted heart could
potentiate this endogenous repair response, prevent infarct
expansion, and improve the recovery of cardiac function
after MI [18]. However, some studies showed the charac-
teristic of c-Kit
? cells derived from heart and bone marrow
is different [1–3, 16, 17]. And in this study, we found
cardiogenic c-Kit
? cells could spontaneously differentiate
into cardiomyocytes in vitro, but bone marrow derived c-
Kit
? cells could not spontaneously differentiate into
cardiomyocytes, bone marrow derived c-Kit
? cells could
differentiate into cardiomyocytes when co-cultured with
cardiomyocytes in vitro [supplement 3]. Although we did
not conﬁrm whether these c-Kit
? cells derived from bone
marrow or heart or not, cadiocytes in infarction and peri-
infarction area increased signiﬁcantly in the Adv-SDF-1
group than the control or Adv-LacZ group. These data
suggested the part of these cardiocytes could derive from
c-Kit
? cardiac stem cells. In addition, SDF-1 has been
recently shown to have additional non-stem cell-recruiting
effects, including increasing stem cell survival. Our and
Zhang’studies showed SDF-1 to the cell surface of injured
cardiac myocytes could lead to inhibition of cardiocytes
apoptosis via SDF-1 inducing up-regulation of prosurvival
signaling [19, 20]. Therefore, these changes could lead to
decrease scar sizes, reduce remodeling and improve cardiac
function, which is a consequence of the increased cardio-
cytes in damaged heart sites.
It is interesting that our study have showed c-Kit
? stem
cells differentiation into endothelial cells were related with
the presence of SDF-1 in vitro [supplement 3]. Recently,
Falco et al. [21] have shown that SDF-1 plays an important
role in differentiation of bone marrow-derived c-kit
? stem
cells into EPCs and endothelial cells. More importantly,
Fazel et al. [22] have shown that bone marrow c-kit
? cells
act as key regulators of the angiogenic switch in infarcted
Fig. 6 Effects of SDF-1 on histology and form. a–d Representative
picture of a myocardial infarction 28 days after surgery, the heart was
exercised, and infarction size was measured by TTC (39). e–h The
infarcted myocardium was unstained by TTC (white, arrow indi-
cated), and the non-ischemic zones stained brick red. i–p Represen-
tative Masson’s trichrome-stained sections in the area of infarcted left
ventricular tissue 28 days after MI (blue, collagen, black arrow
indicated; i–l 39; m–p 4009). There was a decreased infarct size,
thicker LV wall in the AdV.SDF-1 group. The new or survivaling
myocardium (black round arrow indicated) typically appeared as red-
positive cells wedged between an inner and outer layer of collagen
(each group, n = 6) (Color ﬁgure online)
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123myocardium, and SDF-1 promote angiogenesis by
enhancement of EPCs incorporation into new vessels [23].
Furthermore, these stem cells produce a wide array of ar-
teriogenic cytokines and improve perfusion and remodel-
ing in mouse models of hindlimb ischemia, and these
effects appear to be mediated through paracrine mecha-
nisms associated with local release of the arteriogenic
cytokines [22, 24–26]. In our study, VEGF expression level
in the AdV-SDF-1 group obviously increased. Increased
VEGF could involve in or trigger angiogenic progress of
stem cells, even might contribute to postnatal neovascu-
larization by mobilizing bone marrow-derived stem cells
[7–9, 21, 24, 27, 28]. Of course, besides VEGF, released
angiogenic cytokines after MI include ﬁbroblast growth
factor (FGF), hepatocyte growth factor (HGF), and so on
[28]. For example, Rosenblatt-Velin et al. [29] recently
reported that bFGF controls the differentiation of resident
cardiac precursors into functional cardiomyocytes. And
other angiogenic factors contribute to angiogenesis in the
damaged sites [30, 31].Therefore; these cytokines could
contribute to stem cell-mediated regeneration repair of
infarcted myocardium.
In our study, we evaluated the functional improvement
seen in AdV.SDF-1 group by cardiac catheterization to
detect ventricular pressure. The AdV.LacZ group and
control group showed the expected decline in ±dp/dtmax
and LVSP, and markedly increase in LVEDP. In contrast,
and as expected, The AdV.SDF-1 group showed the lower
decline in ±dp/dtmax and LVSP, and the lower increase in
LVEDP. Overexpressing SDF-1 contributed to preserva-
tion of ±dp/dtmax, LVSP and LVEDP in infarct hearts.
Also, histology and morphometric measurement showed
the expected decrease in infarcted size (IS), and obviously
increase in LV wall thickness in AdV.SDF-1 group. And
SDF-1 overexpressing hearts were less dilated and a
combination of less dilatation and a trend toward less
paradoxical systolic bulging probably led to the improved
ventricular pressure. Furthermore, overexpressing SDF-1
could inhibit LV remodeling, augment or preserve the
myocardial elasticity, improve heart function and reduce
Fig. 7 Effects of SDF-1 on infarct size and left ventricle wall
thickness. a Quantitation of collagen content in percent of infarct and
noninfarcted area in multiple ﬁelds. b Thickness of infarct LV wall in
AdV.SDF-1 group is obviously thicker than the infarct LV wall in the
control and AdV.Lac-Z group. Thickness of infarct LV wall in
AdV.SDF-1 group is thinner than the non-infarct LV wall
(
& P = 0.001) and is obviously thicker than the infarct LV wall in
the control or AdV.Lac-Z group (
& P=0.0005). The average LV
wall in the AdV.SDF-1 group is thicker than in the control or
AdV.Lac-Z group (
# P = 0.001) and thinner than in the sham group
(
# P = 0.0003). The non-infarct LV wall in the AdV.SDF-1 group is
thinner than in the sham group (* P = 0.002) and thicker than in the
control or AdV.Lac-Z group (*P= 0.0003). c There were statisti-
cally signiﬁcant differences in infarct size among the control,
AdV.Lac-Z and AdV.SDF-1 groups (mean ± SD). (* P = 0.0006).
d Expansion index analyses in AdV.SDF-1 group showed lower than
control or AdV.Lac-Z group (each group, n = 6)
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123the expression of extracellular matrix genes (eg: Collagen,
et al.). These change of morphous and structure is related
with the increasing of the area and number of cardiac
myocytes within the infarct zone.
More Recently, Shao et al. [23] reported that SDF-1
promoted angiogenesis by enhancement of EPCs incorpo-
ration into new vessels,which was related with upregulation
and activation of matrix metalloproteinase-2 (MMP) and
MMP-9. However, TIMP-2 bound to the membrane in a
hydroxamate insensitive manner specially inhibits MMP-2
activated by the membrane, but not other MMPs. Similarly,
TIMP-1 inhibits MMP-9 activation [32]. Interestingly,
TIMP-1 overexpression in pancreatic cancer cells reduced
angiogenesis and cell implantation, this anti-angiogenic
activity of TIMP-1 involved in part MMP-inhibition [33].
TIMP-2 mediated inhibition of angiogenesis was an MMP-
independent mechanism [34]. Furthermore, TIMPs can
block the angiogenic process at different stages and the
acquisition of an angiogenic phenotype may involve the
suppression of TIMPs expression [32]. For example, TIMPs
can inhibit bFGF-induced human endothelial cell growth
[35]. In our study, we observed that expression of Tissue
inhibitors of metalloproteinases (TIMP1, 2) decreased in
infarction area of myocardium in the AdV-SDF-1 group,
which was concordance with much more stem cells and
blood vessels. These data suggested that angiogenesis
induced by SDF-1 could involve in TIMPs down-regulation
and MMPs up-regulation, which would not only contribute
to create a favorable tissue environment for stem cells
migration, but also promote angiogenesis.
Moreover, TIMPs as multifunctional proteins involved
in LV remodeling. Koch et al. reported that SDF-1 through
transendocardial delivery promoted the degradation of
collagen in peri-infarct area [18]. Collagen synthesis,
which is promoted by TGF-b1, has different signiﬁcance in
infarcted and noninfarcted areas [36]. Our current study
suggested that TGF-b1 down-regulation caused by SDF-1
was associated with decreased collagen accumulation and
down-regulated TIMP-1 expression in the infarction area.
Although production of ﬁbrosis after MI prevents structural
fragility. Previous studies reported that a MMP family was
increased in the postinfarction heart failure models with
permanent occlusion and large infarction and that the
inhibitors beneﬁcially affected cardiac remodeling and
function [36, 37]. Furthermore, myocardial TIMP-1 plays a
regulatory role in post-MI remodeling and the accelerated
myocardial remodeling induced by TIMP-1 gene deletion
can be pharmacologically ‘‘rescued’’ by MMP inhibition
[38]. Thus, it is suggested that a decrease in TIMPs has an
aggravating effect on heart failure via collagen degrada-
tion. However, it is well known that the volume of reactive
granulation and/or scar tissues after skin injury after burn,
surgery, etc, frequently becomes excessive, and this is
called hypertrophic scarring. The excessive extent of
ﬁbrosis without contractility or relaxation would accelerate
cardiac remodeling and decrease cardiac function, as seen
in ischemic or idiopathic dilated cardiomyopathy. Fur-
thermore, an increase in MMPs by hepatocyte growth
factor or G-CSF was beneﬁcial on post-MI heart failure via
its anti-ﬁbrotic action; reduction of scar tissue and
improvement of remodeling were observed simultaneously
in myocardial regeneration therapy [23, 39–41]. In addi-
tion, in the setting of liver injury, MMP-9 is associated
with increased CXCR4 expression on stem cells, and MMP
inhibitors reduce homing of these cells to the liver [42, 43].
Although SDF-1 is cleaved by exopeptidases and matrix
metalloproteinase-2, a new, protease-resistant SDF-1 and
nanoﬁber-mediated delivery promoted recruitment of stem
cells and improved cardiac function after myocardial
infarction [44]. Thus, in the present study, the beneﬁcial
effect of SDF-1 over expression relies on a higher number
of cardiocytes and blood vessels and down-regulation of
TIMPs and increased participation of mobilized stem cells,
which supports the concept of myocardial repair mediated
by stem cells after infarction.
Conclusion
our data are consistent with the concept that there is a
naturally occurring regenerative repair process that occurs
in infarcted myocardium that can be enhanced through the
over-expression of SDF-1a within the myocardium after
MI. Over-expressing SDF-1a improved cardiac structure
and function through the symphysial effect of myogenesis
and angiogenesis.
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